Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib

Clinical trial NCT06206850 · RECRUITING

Trial details

NCT number: NCT06206850
Sponsor: Jair Bar, M.D., Ph.D.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-squamous NSCLC

Start date: 2024-02-19
Primary completion: 2029-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.